Article
Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma.
PloS one - 1 Jan 2014
Liu Dan, Lu Yachao, Hu Zhenli, Wu Ning, Nie Xiaomeng, Xia Yang, Han Yiping, Li Qiang, Zhu Guanshan, Bai Chong
Abstract excerpt
BACKGROUND: Though the possibility of using malignant pleural effusions (MPEs) as alternatives for metastatic pleural tumor tissues (MPTTs) in epidermal growth factor receptor (EGFR) mutation test has been examined, due to the lack of studies comparing the results in matching MPEs and MPTTs, the clinical value of MPEs for advanced adenocarcinoma patients with pleural effusions is not confirmed. METHODS: EGFR...
Topics
Join the communities discussing this publication.
